As of Feb 27
| -0.24 / -5.05%|
The 4 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 7.75, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +71.84% increase from the last price of 4.51.
The current consensus among 7 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.